ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P 500
5,505.00
0.00%
US Tech 100
19,216.40
1.09%
Dow Jones
40,287.53
0.00%
Brent Oil
81.225
-1.28%
Bitcoin
67,706.48
-0.66%
Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Immunovant Inc (IMVT)

  7. Immunovant Inc (IMVT) News

IMVT

Immunovant (IMVT)

Immunovant Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:IMVT
DateTimeSourceHeadlineSymbolCompany
07/19/20245:41PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IMVTImmunovant Inc
07/19/20245:39PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IMVTImmunovant Inc
07/19/20245:38PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IMVTImmunovant Inc
07/19/20245:36PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IMVTImmunovant Inc
07/10/20245:07PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IMVTImmunovant Inc
07/10/20245:06PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IMVTImmunovant Inc
07/10/20245:04PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IMVTImmunovant Inc
05/29/20244:36PMEdgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:IMVTImmunovant Inc
05/29/20244:17PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:IMVTImmunovant Inc
05/29/20244:01PMGlobeNewswire Inc.Immunovant Provides Corporate Updates and Reports Financial Results for the Fourth Quarter and Fiscal Year Ended March 31, 2024NASDAQ:IMVTImmunovant Inc
05/24/20244:18PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IMVTImmunovant Inc
05/24/20244:15PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IMVTImmunovant Inc
05/24/20244:14PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IMVTImmunovant Inc
05/24/20244:13PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IMVTImmunovant Inc
03/12/20247:30AMGlobeNewswire Inc.Immunovant Awarded U.S. Patent for IMVT-1402NASDAQ:IMVTImmunovant Inc
02/23/20244:21PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IMVTImmunovant Inc
02/23/20244:16PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IMVTImmunovant Inc
02/23/20244:11PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IMVTImmunovant Inc
02/14/20248:47AMEdgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:IMVTImmunovant Inc
02/12/20247:05AMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:IMVTImmunovant Inc
02/12/20247:02AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:IMVTImmunovant Inc
01/29/20244:11PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IMVTImmunovant Inc
01/19/20244:04PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IMVTImmunovant Inc
01/16/20247:29AMEdgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:IMVTImmunovant Inc
01/12/20244:34PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IMVTImmunovant Inc
01/09/20244:20PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IMVTImmunovant Inc
01/09/20244:18PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IMVTImmunovant Inc
01/09/20248:08AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:IMVTImmunovant Inc
01/03/20248:00AMGlobeNewswire Inc.Immunovant to Present at the 42nd Annual J.P. Morgan Healthcare ConferenceNASDAQ:IMVTImmunovant Inc
12/20/20235:40PMDow Jones NewsImmunovant Gets Positive Data From Graves' Disease Treatment TrialNASDAQ:IMVTImmunovant Inc
 Showing the most relevant articles for your search:NASDAQ:IMVT

Your Recent History

USOTC
KBLB
Kraig Biocraft Laborator... (QB)
USOTC
BIEL
Bioelectronics (PK)
USOTC
SPZI
Spooz (PK)
USOTC
HIRU
Hiru (PK)
USOTC
RONN
Ronn Motor (PK)
USOTC
VPLM
Voip Pal Com (QB)
COIN
BTCUSD
Bitcoin
USOTC
AABB
Asia Broadband (PK)
NASDAQ
LWLG
Lightwave Logic
NASDAQ
COOP
Mr Cooper
NASDAQ
AVXL
Anavex Life Sciences
USOTC
BLEG
Branded Legacy (PK)
USOTC
NWBO
Northwest Biotherapeutics (QB)
USOTC
DBMM
Digital Brand Media and ... (PK)
NASDAQ
MAXN
Maxeon Solar Technologies
USOTC
NSAV
Net Savings Link (PK)
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

United States
Company
Business
Popular
Get The App
App Store
Google Play

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved